Age (years) |
62.00 (50-70) |
Female |
96 (32.76%) |
Race |
|
White |
263 (89.76%) |
Black |
24 (8.19%) |
Other |
6 (2.05%) |
Body mass index (kg/m2) |
28.14
(24.69-32.30) |
Body surface area (m2) |
2.03 (0.28) |
Diabetes mellitus |
58 (19.80%) |
Dialysis dependency |
11 (3.75%) |
Chronic obstructive pulmonary disease |
75 (25.60%) |
Hypertension |
218 (74.40%) |
Immunosuppression |
24 (8.19%) |
Cerebrovascular disease |
71 (24.23%) |
Peripheral vascular disease |
96 (32.76%) |
Previous myocardial infarction |
70 (23.89%) |
NYHA class symptoms |
|
1 |
191 (65.19%) |
2 |
13 (4.44%) |
3 |
45 (15.36%) |
4 |
44 (15.02%) |
History of CHF |
92 (31.40%) |
Cardiac arrhythmia |
114 (38.91%) |
Serum creatinine (mg/dL) |
1.00 (0.80- 1.20) |
Total bilirubin (mg/dL) |
0.80 (0.50- 1.10) |
Total albumin (g/dL) |
|
≤3.20 |
62 (21.16%) |
3.20-3.70 |
69 (23.55%) |
3.70-4.00 |
41 (13.99%) |
>4.00 |
57 (19.45%) |
Not measured |
64 (21.84%) |
Left ventricular ejection fraction (%) |
55.00
(50.00-60.00) |
STS predicted risk of mortality (%) |
2.51 (1.32- 4.70) |